Genomic Insights into Myasthenia Gravis Identify Distinct Immunological Mechanisms in Early and Late Onset Disease.

Publication Year: 2021

DOI:
10.1002/ana.26169

PMCID:
PMC8581766

PMID:
34279044

Journal Information

Full Title: Ann Neurol

Abbreviation: Ann Neurol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"gene expression data sets used in this study are already available from the ncbi gene expression omnibus (accession code: gse78840) and arrayexpress (accession codes: e-mtab-945 e-mtab-2232 and e-mtab-3536)."

Code Sharing
Evidence found in paper:

"Potential Conflict of Interests No conflicts of interests to declare."

Evidence found in paper:

"L.H. is supported by the National Institute for Health Research (NIHR). J.C.K. is supported by the Wellcome Trust (WT204969/Z/16/Z), NIHR Oxford Biomedical Research Centre, and the European Commission (Innovative Medicine Initiative). S.R.I. is supported by the Wellcome Trust and by the NIHR Oxford Biomedical Research Centre. The Wellcome Sanger Institute is supported by core funding from the Wellcome Trust (206194). The views expressed in this study are those of the authors and not necessarily those of the funding bodies. We would likely thank Dr. Defne Saatci and Professor Nick Willcox for helpful discussions about this manuscript."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025